Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DSKE | Common Stock | Options Exercise | $0 | +6.91K | +1.4% | $0.00 | 501K | Jan 1, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DSKE | Restricted Stock Unit | Award | $0 | +4.98K | +72.11% | $0.00 | 11.9K | Dec 31, 2021 | Common Stock | 4.98K | Direct | F2, F3, F4 | |
transaction | DSKE | Restricted Stock Unit | Options Exercise | $0 | -6.91K | -58.1% | $0.00 | 4.98K | Jan 1, 2022 | Common Stock | 6.91K | Direct | F1, F2, F4 |
Id | Content |
---|---|
F1 | The Reporting Person received 6,906 restricted stock units ("RSUs"), which convert into shares of the Issuer's common stock on a one-for-one basis, on June 1, 2021. These RSUs fully vested on January 1, 2022 and were settled in shares of the Issuer's common stock. |
F2 | Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
F3 | As compensation for their performance as a director in 2022, the Reporting Person received 4,980 RSUs, which shall fully vest on January 1, 2023, if Reporting Person remains a director. Upon vesting, such RSUs will be settled in shares of the Issuer's common stock. |
F4 | Not applicable. |